证券代码：603379 证券简称：三美股份 浙江三美化工股份有限公司 2023 年 11 月 21、24 日投资者关系活动记录表 编号：2023-1124-016 投资者关系 þ特定对象调研 ¨分析师会议 ¨媒体采访 ¨业绩说明会 活动类别 ¨新闻发布会 ¨路演活动 ¨现场参观 þ线上会议 参与单位及 国金证券：陈屹、杨翼荥、任建斌 人员 中邮证券：候若雪 汇添富：黄耀峰、李华伟、顾耀强、李超、胡昕炜、刘高晓、 高田昊 时间 2023年11月21日下午14:45--16:00、24日下午13:30--14:15 地点 公司会议室 公司接待 董事会秘书林卫 人员 ...

证券代码：603379 证券简称：三美股份 浙江三美化工股份有限公司 2023 年 11 月 16 日投资者关系活动记录表 编号：2023-1116-015 投资者关系 þ特定对象调研 ¨分析师会议 ¨媒体采访 ¨业绩说明会 活动类别 ¨新闻发布会 ¨路演活动 þ现场参观 ¨线上会议 参与单位及 长江证券：王呈 人员 银华基金：施航 时间 2023年11月16日上午9:00--10:00 地点 公司会议室 公司接待 董事会秘书林卫 人员 主要内容 Q：2024年度HFCs配额申请情况？ 介绍 A：根据《2024 年度氢氟碳化物配额总量设定与分配方 ...

证券代码：603379 证券简称：三美股份 浙江三美化工股份有限公司 2023 年 11 月 10、13 日投资者关系活动记录表 编号：2023-1113-014 投资者关系 þ特定对象调研 ¨分析师会议 ¨媒体采访 ¨业绩说明会 活动类别 ¨新闻发布会 ¨路演活动 ¨现场参观 þ线上会议 参与单位及 中欧基金：王习、李波 人员 东方红：向仕杰 时间 2023年11月10日上午10:00--10:50、13日下午15:00--15:30 地点 公司会议室 公司接待 董事会秘书林卫 人员 主要内容 Q：去年四季度，海外、国内的流通及终端环节都有囤货的 介绍 行为；今年是否也会有？ ...

证券代码：603379 证券简称：三美股份 浙江三美化工股份有限公司 2023 年 11 月 6-7 日投资者关系活动记录表 编号：2023-1107-013 投资者关系 þ特定对象调研 ¨分析师会议 ¨媒体采访 ¨业绩说明会 活动类别 ¨新闻发布会 ¨路演活动 ¨现场参观 þ线上会议 参与单位 申万宏源：马昕晔、宋涛、姚远 及人员 华泰保险：杨林夕、徐笔龙 平安养老：袁帅、高高 时间 2023年11月6日、7日下午15:00--15:40 地点 公司会议室 公司接待人 董事会秘书林卫 员 主要内容介 Q：对制冷剂产品价格的看法？ ...

证券代码：603379 证券简称：三美股份 浙江三美化工股份有限公司 2023 年第三季度业绩说明会投资者关系活动记录表 投资者关系活动 ¨特定对象调研 ¨分析师会议 ¨媒体采访 þ业绩说明会 类别 ¨新闻发布会 ¨路演活动 ¨现场参观 ¨电话会议 参与单位及人员 投资者 时间 2023年11月3日下午15：00~16：00 地点 线上交流 董事长、总经理胡淇翔；财务总监潘彩玲；董事会秘书林卫； 公司接待人员 独立董事张陶勇 投资者关系活动 Q：公司8月份公告建设3500万瓶制冷剂生产线及配套设施。可 主要内容介绍 否请教： 当前市面上销售的瓶装三美制冷剂（比如 200g一瓶的R134a）, 是以下哪种方式生产销售的： a.公司按照市场价格销售制冷剂给分销商，分销商灌装及销售 b.公司委托第三方灌装，而后将灌装后的成品交给分销商销售 c.其它方式，辛苦说明 A：公司部分制冷剂产品委托第三方灌装。产品销售采用直销和 经销相结合的模式。谢谢！ Q：后续公司3500万瓶制冷剂生产线建设完成后，预期哪种制 冷剂(R32,R125,R410a,R134a)的瓶装会占比比较高？公司自己灌装的 ...

2023 年第三季度报告 单位：元 币种：人民币 证券代码：603379 证券简称：三美股份 浙江三美化工股份有限公司 2023 年第三季度报告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真实、准确、完整， 不存在虚假记载、误导性陈述或重大遗漏，并承担个别和连带的法律责任。 公司负责人、主管会计工作负责人及会计机构负责人（会计主管人员）保证季度报告中财务 信息的真实、准确、完整。 第三季度财务报表是否经审计 □是 √否 一、主要财务数据 (一)主要会计数据和财务指标 | --- | --- | --- | --- | --- | |-----------------------------------------------|----------------|----------------------------------------|------------------|---------------------------------- ...

证券代码：603379 证券简称：三美股份 浙江三美化工股份有限公司 2023 年 10 月 17 日投资者关系活动记录表 编号：2023-1017-012 投资者关系 þ特定对象调研 ¨分析师会议 ¨媒体采访 ¨业绩说明会 活动类别 ¨新闻发布会 ¨路演活动 þ现场参观 þ线上会议 参与单位 国信证券：林扬、张玮航，鹏华基金：王曦炜，汇添富基 及人员 金：刘高晓，华夏基金：贾静雯，银华基金：吴颖，财通基 金：张玉龙 浙商证券：陈海波、刘子源，国寿资产：胡心瀚、戴梦、孙 利萍、高奕昂、龚诚 时间 2023年10月17日上午10:30--11:20、下午15:00--16:30 地点 公司会议室 公司接待人 ...

2023 年半年度报告 公司代码：603379 公司简称：三美股份 浙江三美化工股份有限公司 2023 年半年度报告 1/149 2023 年半年度报告 重要提示 一、本公司董事会、监事会及董事、监事、高级管理人员保证半年度报告内容的真实性、准确性、 完整性，不存在虚假记载、误导性陈述或重大遗漏，并承担个别和连带的法律责任。 二、公司全体董事出席董事会会议。 三、本半年度报告未经审计。 四、公司负责人胡淇翔、主管会计工作负责人潘彩玲及会计机构负责人（会计主管人员）何燕露 声明：保证半年度报告中财务报告的真实、准确、完整。 五、董事会决议通过的本报告期利润分配预案或公积金转增股本预案 无 六、前瞻性陈述的风险声明 √适用 □不适用 本报告包括前瞻性陈述。除历史事实陈述外，所有本公司预计或期待未来可能或即将发生的 业务活动、事件或发展动态的陈述（包括但不限于预测、目标、估计及经营计划）都属于前瞻性 陈述。受诸多可变因素的影响，未来的实际结果或发展趋势可能会与这些前瞻性陈述出现重大差 异。本报告中的前瞻性陈述为本公司于2023年8月23日作出，不构成公司对投资者的实质承诺，投 资者及相关人士均应当对此保持足够的风险 ...

Financial Performance - The company's operating revenue for 2022 was approximately ¥4.77 billion, representing a year-over-year increase of 17.84% compared to ¥4.05 billion in 2021[16]. - The net profit attributable to shareholders for 2022 was approximately ¥485.57 million, a decrease of 9.44% from ¥536.17 million in 2021[16]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was approximately ¥451.10 million, down 6.79% from ¥483.98 million in 2021[16]. - The net cash flow from operating activities for 2022 was approximately ¥628.73 million, an increase of 158.22% compared to ¥243.49 million in 2021[16]. - The total assets at the end of 2022 were approximately ¥6.43 billion, reflecting a 6.26% increase from ¥6.05 billion at the end of 2021[16]. - The net assets attributable to shareholders at the end of 2022 were approximately ¥5.71 billion, up 7.97% from ¥5.29 billion at the end of 2021[16]. - The weighted average return on equity decreased by 1.46 percentage points to 8.84%[1]. - The company reported a basic earnings per share of CNY 0.80, down 9.09% from CNY 0.88 in the previous year[1]. Dividend Policy - The company plans to distribute a cash dividend of 2.39 CNY per 10 shares, totaling approximately 145.90 million CNY (including tax) based on a total share capital of 610,479,037 shares as of December 31, 2022[2]. - The company has established a cash dividend policy, stating that the total cash dividends should not be less than 20% of the audited net profit attributable to shareholders in the current year[156]. - The cash dividend represents 19.36% of the net profit attributable to ordinary shareholders in the consolidated financial statements, which amounted to 536,168,573.50 RMB[161]. - The total dividend amount, including cash buybacks, is 268,605,244.78 RMB, accounting for 50.10% of the net profit attributable to ordinary shareholders[161]. - The company maintains a cash dividend policy where at least 40% of profits are distributed as cash dividends during the mature stage of development with significant capital expenditures[157]. - The company has not made any adjustments to its profit distribution policy during the reporting period[158]. Corporate Governance - The company has established a robust governance structure, holding three shareholder meetings during the reporting period to ensure transparency and protect shareholder rights[122]. - The company held 6 board meetings during the reporting period, with 9 current directors, including 3 independent directors, ensuring compliance with legal regulations[123]. - The company established a comprehensive performance evaluation system for senior management, linking compensation closely to performance, with core management holding shares in the company[125]. - The company maintained strict independence from its controlling shareholders and related parties in personnel, assets, finance, and operations, ensuring independent accounting and risk management[126]. - The company engaged in effective communication with investors through various channels, ensuring fair treatment of institutional and retail investors[126]. - The company emphasized environmental protection and social responsibility, increasing investment in environmental governance and supporting community welfare initiatives[126]. Risk Management - The company has outlined potential risks and corresponding countermeasures in the report, particularly in the section discussing future development[4]. - The company is addressing cyclical industry risks by closely monitoring macroeconomic conditions and downstream market demands, which significantly impact the fluorochemical sector[116]. - The company is facing a cyclical downturn in the fluorochemical industry, primarily due to oversupply and price declines[111]. - The company anticipates that the supply-demand relationship will improve as HFCs quota policies are implemented and industry capacity contracts during the downturn[111]. - The company is monitoring foreign exchange risks related to its export activities and will utilize financial instruments like forward contracts to mitigate these risks[120]. Environmental and Social Responsibility - The company invested 13.8011 million yuan in environmental protection during the reporting period[168]. - The total emissions of nitrogen oxides were 3.6193 tons, with a concentration of 11.627 mg/m³, well below the standard of 35 mg/m³[169]. - The total emissions of sulfur dioxide were 0.8513 tons, with a concentration of 2.683 mg/m³, below the standard of 50 mg/m³[169]. - The company has established an environmental protection mechanism and is classified as a key pollutant discharge unit[168]. - The company has implemented emergency response plans for environmental incidents, including comprehensive and specialized plans for hazardous chemical accidents and flood prevention[174]. - The company invested 2.8578 million yuan in social responsibility initiatives, benefiting 4,526 individuals through various charitable activities[183]. Research and Development - The company has invested in 28 R&D projects focusing on optimizing production processes and developing new products, including environmentally friendly refrigerants and fine chemicals[87]. - The company holds 96 authorized patents and has 43 pending patent applications, primarily in the fields of production processes and environmental technologies[87]. - Research and development expenses rose by 42.82% to CNY 38,310,662.41, reflecting increased investment in R&D projects[48]. Production Capacity and Operations - The company has a production capacity of 131,000 tons for anhydrous hydrofluoric acid (AHF), which helps in managing costs and enhancing profitability[26]. - The company has a production capacity of 65,000 tons for HFC-134a, 52,000 tons for HFC-125, 40,000 tons for HFC-32, and 10,000 tons for HFC-143a, making HFCs refrigerants the company's primary product[41]. - The company has a production capacity of 14,400 tons for HCFC-22, with 11,800 tons allocated for refrigerant production, accounting for 5.25% of the national production quota[37]. - The company has a production capacity of 35,600 tons for HCFC-141b, with 28,000 tons allocated for foaming agent production, representing 55.05% of the national production quota[38]. - The company is expanding AHF production capacity from 31,000 tons to 90,000 tons through ongoing projects[97]. Market Position and Strategy - The company is focusing on the integration of the industrial chain with investments in fluorinated refrigerants, fine chemicals, and polymers to foster new growth points[32]. - The company aims to become a leading manufacturer of refrigerants and fluorinated chemicals, with a focus on HFCs and fluoropolymer products[112]. - The company is committed to maintaining its market position in HFCs refrigerants while developing new environmentally friendly refrigerants and expanding into high-value products like fluoropolymers and fine chemicals[117]. Shareholder Engagement - The company ensures that minority shareholders have sufficient opportunities to express their opinions and that their legal rights are fully protected[159]. - The independent directors have fulfilled their responsibilities and played a significant role in the decision-making process regarding profit distribution[159]. - The company has committed to repurchase all newly issued shares within 3 trading days if any false statements or omissions are identified in the prospectus, with the repurchase price being the lower of the market price or the issuance price[194].

Financial Performance - The company's operating revenue for Q1 2023 was RMB 777,604,061.17, a decrease of 34.12% compared to the same period last year[4] - The net profit attributable to shareholders was RMB 19,972,241.76, down 89.65% year-on-year[4] - The net profit attributable to shareholders after deducting non-recurring gains and losses was RMB 21,718,081.36, a decline of 87.66% compared to the previous year[4] - The basic earnings per share were RMB 0.03, reflecting a decrease of 90.63% year-on-year[4] - Total operating revenue for Q1 2023 was RMB 777.60 million, a decrease of 34% compared to RMB 1,180.42 million in Q1 2022[16] - Net profit for Q1 2023 was RMB 19.97 million, a significant decline of 90.6% from RMB 192.99 million in Q1 2022[17] - Total profit for Q1 2023 was RMB 26.11 million, down 89.8% from RMB 254.98 million in Q1 2022[17] Assets and Liabilities - Total assets at the end of the reporting period were RMB 6,286,080,232.07, down 2.23% from the end of the previous year[5] - The company's current assets totaled RMB 4,524,933,632.09, down from RMB 4,733,362,572.34, indicating a decrease of about 4.41%[12] - Total liabilities decreased to RMB 548,846,911.08 from RMB 720,106,748.11, a significant decline of approximately 23.8%[14] - The company's equity attributable to shareholders increased to RMB 5,737,233,320.99 from RMB 5,709,667,982.73, reflecting a slight increase of about 0.48%[15] Cash Flow - The company reported a net cash flow from operating activities of RMB 222,854,466.72, a decrease of 5.99% year-on-year[4] - Cash inflow from operating activities in Q1 2023 was RMB 782.22 million, down 31% from RMB 1,136.71 million in Q1 2022[19] - The net cash flow from operating activities was $222,854,466.72, a decrease of 6.1% compared to $237,046,946.14 in the previous period[20] - Cash outflow from operating activities totaled $559,365,928.72, down from $899,663,946.89, indicating a significant reduction in operational cash expenses[20] - The total cash and cash equivalents at the end of the period reached $3,622,900,826.13, an increase from $2,037,320,323.71, showing strong liquidity position[20] Operational Metrics - The decline in revenue and profit was primarily due to a decrease in both sales volume and sales prices[7] - The weighted average return on equity was 0.35%, a decrease of 3.23 percentage points compared to the previous year[4] - Research and development expenses increased to RMB 8.82 million in Q1 2023, up 36% from RMB 6.49 million in Q1 2022[16] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 16,810[9] Other Financial Activities - The company reported a foreign currency translation loss of RMB 110.88 in Q1 2023, compared to a loss of RMB 873.80 in Q1 2022[18] - Investment loss for Q1 2023 was RMB 1.86 million, compared to a gain of RMB 2.60 million in Q1 2022[17] - Other income for Q1 2023 was RMB 1.27 million, a decrease of 48.7% from RMB 2.48 million in Q1 2022[17] - The company has not participated in margin financing or securities lending activities during the reporting period[10] - There are no significant new product developments or market expansion strategies mentioned in the report[11]